Nucleotide Prodrug Containing a Nonproteinogenic Amino Acid To Improve Oral Delivery of a Hepatitis C Virus Treatment

Authors:

Abstract
Delivery of pharmacologically active nucleoside triphosphate analogs to sites of viral infection is challenging. In prior work we identified a 2′- C -methyl-1′-cyano-7-deaza-adenosine C -nucleotide analog with desirable selectivity and potency for the treatment of hepatitis C virus (HCV) infection.
Funding Information
  • Gilead Sciences (NA)

This publication has 24 references indexed in Scilit: